JP2018040799A5 - - Google Patents

Download PDF

Info

Publication number
JP2018040799A5
JP2018040799A5 JP2017171651A JP2017171651A JP2018040799A5 JP 2018040799 A5 JP2018040799 A5 JP 2018040799A5 JP 2017171651 A JP2017171651 A JP 2017171651A JP 2017171651 A JP2017171651 A JP 2017171651A JP 2018040799 A5 JP2018040799 A5 JP 2018040799A5
Authority
JP
Japan
Prior art keywords
assay result
sample
assay
lipid
measurement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017171651A
Other languages
English (en)
Japanese (ja)
Other versions
JP7022538B2 (ja
JP2018040799A (ja
Filing date
Publication date
Priority claimed from EP16187839.2A external-priority patent/EP3293521B1/de
Application filed filed Critical
Publication of JP2018040799A publication Critical patent/JP2018040799A/ja
Publication of JP2018040799A5 publication Critical patent/JP2018040799A5/ja
Application granted granted Critical
Publication of JP7022538B2 publication Critical patent/JP7022538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017171651A 2016-09-08 2017-09-07 脂質妨害の決定のための脂肪血症血漿または血清試料の調製 Active JP7022538B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16187839.2 2016-09-08
EP16187839.2A EP3293521B1 (de) 2016-09-08 2016-09-08 Herstellung lipämischer plasma- oder serumproben für die bestimmung einer lipidinterferenz

Publications (3)

Publication Number Publication Date
JP2018040799A JP2018040799A (ja) 2018-03-15
JP2018040799A5 true JP2018040799A5 (https=) 2020-09-03
JP7022538B2 JP7022538B2 (ja) 2022-02-18

Family

ID=56936286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017171651A Active JP7022538B2 (ja) 2016-09-08 2017-09-07 脂質妨害の決定のための脂肪血症血漿または血清試料の調製

Country Status (6)

Country Link
US (1) US10488308B2 (https=)
EP (1) EP3293521B1 (https=)
JP (1) JP7022538B2 (https=)
CN (1) CN107807024B (https=)
CA (1) CA2978476C (https=)
ES (1) ES2720779T3 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2951329T3 (es) * 2019-01-29 2023-10-19 Siemens Healthcare Diagnostics Inc Algoritmo de normalización de la turbidez y métodos para reducir la interferencia de intralípido/lipemia en los ensayos de hemoglobina A1c
CN111929449A (zh) * 2020-08-28 2020-11-13 保定天岳生物工程有限公司 一种aptt检测试剂盒
CN116422481A (zh) * 2022-01-11 2023-07-14 汾沃有限公司 基于脂质浓度对离心机中的目标界面位置进行调整
CN116907961A (zh) * 2023-06-27 2023-10-20 郴州市第一人民医院 一种消减脂血标本血脂干扰的方法
CN119901692B (zh) * 2023-10-28 2025-12-02 柏荣诊断产品(上海)有限公司 一种减弱脂血对透散射融合增强免疫比浊检测影响的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4977685A (https=) * 1972-11-29 1974-07-26
DE4223355A1 (de) * 1992-07-16 1994-01-20 Boehringer Mannheim Gmbh Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben
JP4273311B2 (ja) 2002-04-26 2009-06-03 株式会社シノテスト 試料中の測定対象物質の測定方法及び測定試薬
CN101398422B (zh) * 2008-10-28 2012-09-05 四川大学华西医院 高甘油三脂对血红蛋白浓度测定干扰的消除方法
US20130084592A1 (en) 2011-10-04 2013-04-04 Siemens Healthcare Diagnostics Inc. Methods for correcting assay measurements

Similar Documents

Publication Publication Date Title
JP2018040799A5 (https=)
MA46917A (fr) Anticorps anti-met, molécules de liaison à un antigène bispécifique se liant à met, et leurs procédés d'utilisation
CL2019003114A1 (es) Anticuerpos anti–tau y métodos de uso (divisional solicitud 201703063)
BR112019000970A2 (pt) proteínas de ligação ao antígeno multiespecíficas e métodos de uso das mesmas
MA43982A (fr) Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1
BR112018070260A2 (pt) receptores quiméricos e métodos de uso dos mesmos
EP4582812A3 (en) Assays for detecting the presence or amount of an anti-drug antibody
WO2017120523A3 (en) Anti-pro/latent myostatin antibodies and methods of use thereof
BR112013023540A2 (pt) anticorpo, kit e método para a determinação de peptídeos amilóides
WO2014015194A3 (en) Methods for detecting and measuring aggregation
WO2016050822A3 (en) Human-derived anti-dipeptide repeats (dprs) antibody
EP4356927A3 (en) Antibody based reagents that specifically recognize toxic oligomeric forms of tau
CA2872308A1 (en) Novel ha binding agents
EP3464346A4 (en) ANTIBODIES, COMPOSITION AND KITS THEREFOR AND METHOD FOR USE THEREOF
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
WO2017194903A8 (fr) Particule virale pour le transfert d'arns, notamment dans les cellules impliquées dans la réponse immune
JP2018528441A5 (https=)
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
WO2015148609A3 (en) Immunoassays using colloidal crystals
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
WO2015143194A3 (en) Immunogenetic restriction on elicitation of antibodies
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
WO2018138681A9 (en) Hemagglutinin-specific antibodies and uses thereof
WO2009108170A3 (en) Compositions and methods for determining immune status
WO2017156038A3 (en) Immunoassay controls and the use thereof